Galmed Pharmaceuticals Stock Price on September 23, 2024
| GLMD Stock | USD 2.68 0.02 0.74% |
Below is the normalized historical share price chart for Galmed Pharmaceuticals extending back to March 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Galmed Pharmaceuticals stands at 2.68, as last reported on the 7th of February, with the highest price reaching 2.74 and the lowest price hitting 2.65 during the day.
If you're considering investing in Galmed Stock, it is important to understand the factors that can impact its price. Galmed Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.012, which attests that the entity had a -0.012 % return per unit of risk over the last 3 months. Galmed Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Galmed Pharmaceuticals' Risk Adjusted Performance of (0.05), market risk adjusted performance of (0.42), and Standard Deviation of 3.9 to validate the risk estimate we provide.
At present, Galmed Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 252.4 K, whereas Common Stock Total Equity is forecasted to decline to about 41.4 K. . At present, Galmed Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.08, whereas Price Earnings To Growth Ratio is forecasted to decline to (0). Galmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of March 2014 | 200 Day MA 3.8875 | 50 Day MA 2.9237 | Beta 0.798 |
Galmed |
Sharpe Ratio = -0.012
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GLMD |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Galmed Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galmed Pharmaceuticals by adding Galmed Pharmaceuticals to a well-diversified portfolio.
Related Headline
Adverum Biotechnologies Headline on 23rd of September 2024
Acquisition by Soparkar Peter of 450000 shares of Adverum Bi... by Soparkar Peter
Filed transaction by Adverum Biotechnologies Officer Chief Operating Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Galmed Pharmaceuticals Valuation on September 23, 2024
It is possible to determine the worth of Galmed Pharmaceuticals on a given historical date. On September 23, 2024 Galmed was worth 9.79 at the beginning of the trading date compared to the closed value of 9.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Galmed Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Galmed Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Galmed Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Galmed Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 9.85 | 12.60 | 8.36 | 9.35 | 15,047,620 | |
09/23/2024 | 9.79 | 11.19 | 9.04 | 9.35 | 2,282,408 |
| 9.76 | 10.00 | 7.80 | 8.05 | 750,671 |
| Backtest Galmed Pharmaceuticals | | | Galmed Pharmaceuticals History | | | Galmed Pharmaceuticals Valuation | Previous | Next |
Galmed Pharmaceuticals Trading Date Momentum on September 23, 2024
| On September 24 2024 Galmed Pharmaceuticals was traded for 8.05 at the closing time. The top price for the day was 10.00 and the lowest listed price was 7.80 . The trading volume for the day was 750.7 K. The trading history from September 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 13.90% . The overall trading delta against the current closing price is 45.99% . |
Galmed Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Galmed Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Galmed Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Galmed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Galmed Pharmaceuticals Stock history
Galmed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galmed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galmed Pharmaceuticals stock prices may prove useful in developing a viable investing in Galmed Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 207.7 K | 197.3 K | |
| Net Loss | -25.9 M | -24.6 M |
Galmed Pharmaceuticals Quarterly Net Working Capital |
|
Galmed Pharmaceuticals Stock Technical Analysis
Galmed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Galmed Pharmaceuticals Period Price Range
Low | February 7, 2025
| High |
0.00 | 0.00 |
Galmed Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Galmed Pharmaceuticals February 7, 2025 Market Strength
Market strength indicators help investors to evaluate how Galmed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galmed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Galmed Pharmaceuticals stock market strength indicators, traders can identify Galmed Pharmaceuticals entry and exit signals to maximize returns
Galmed Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Galmed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Galmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.43) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Galmed Stock analysis
When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |